Our mission is to make life better for patients suffering with debilitating diseases – and we believe our medicines will redefine what’s possible.
That means raising the bar for treatment expectations in the field of immunology, as we develop and launch medicines that may reduce the burden of diseases such as psoriasis, psoriatic arthritis, rheumatoid arthritis, lupus and gastrointestinal disorders.
We embrace the challenge. Together, we'll redefine what's possible.
There are millions of people worldwide living with debilitating autoimmune diseases who make compromises every day because of chronic pain and fear of how they may be viewed. With a clear focus, we aim to meaningfully change the standard of care to make life better for people around the world.
Ilya YuffaSenior Vice President and President, Lilly Bio-Medicines